Refine by
Hospital Research Articles & Analysis
57 news found
Its solution is relied upon by a growing number of hospitals and private medical laboratories, as well as for biopharmas seeking to harness the potential of genomics in drug discovery. ...
Under the agreement, Chimeric gains exclusive global rights to the CORE-NK platform for oncology, where Chimeric and CWRU are currently advancing multiple product candidates in Dr Wald’s laboratory under the recently announced Sponsored Research Agreement. Chimeric also receives exclusive global rights to the CORE-NK platform for immune disorders and viral infectious ...
“We are excited to expand our common mission and work with the world’s top research hospital and its drug discovery programs.” Under the terms of the collaboration agreement, VeriSIM will leverage its proprietary BIOiSIM™ platform and Translational Index™ approach to reduce the number of outsourced preclinical experiments and help ...
BOSTON & BRUSSELS--(BUSINESS WIRE)--Neutron Therapeutics, Inc (NT) and the University Hospital of Brussels (H.U.B) today announced that they have signed a Letter of Intent to place a nuBeam® suite for Boron-Neutron Capture Therapy (BNCT) at the Institut Jules Bordet (IJB), Erasmus Campus, Anderlecht. nuBeam® is the world’s safest and most powerful ...
BOSTON & BRUSSELS--(BUSINESS WIRE)--Neutron Therapeutics, Inc (NT) and the University Hospital of Brussels (H.U.B) today announced that they have signed a Letter of Intent to place a nuBeam® suite for Boron-Neutron Capture Therapy (BNCT) at the Institut Jules Bordet (IJB), Erasmus Campus, Anderlecht. nuBeam® is the world’s safest and most powerful ...
Backed through funding from the Vaccines Taskforce and National Institute for Health Research (NIHR), the Com-COV 3 trial will seek to recruit 270 volunteers across the UK. ...
“As the principal investigator in the study we are thankful for the hard work of the research team from Akron Children’s Hospital. We also appreciate the coordination and communication demonstrated in this study by all of the researchers in this multicenter ...
ABK Biomedical, Inc., an innovative, clinical-stage medical device company dedicated to the research, development and commercialization of advanced imageable embolic therapies, announced the first patient treated in ABK’s First-in-Human study with Eye90 microspheres™, a Y90 radioembolization device for the treatment of liver cancers. This study is being conducted in ...
Recent peer-reviewed research has also suggested the following benefits among patients using the SmartMat at home: 71% elimination of amputations; 52% reduction in all-cause hospitalizations; 40% reduction in emergency department visits; and a 26% reduction in outpatient visits. ...
Jutras-Aswad and the University of Montreal Hospital Research Centre (Centre de recherche du Centre hospitalier de l'Université de Montréal, ("CRCHUM"). ...
” About the DA01 Phase 1 Trial In Canada, the trial is being conducted in partnership with University Health Network, Canada’s largest research and teaching hospital network, located in Toronto, Ontario under the guidance of Dr. ...
CMR Surgical (CMR) – a global surgical robotics business – today announced the introduction of the Versius® Surgical Robotic System, at Policlinico di Milano, a leading research hospital and care institute (IRCCS), and one of the largest healthcare facilities in Lombardy, Italy. Within the hospital, Versius will be used in a ...
” Co-authors also include Wei-Chiao Huang and Breandan Quinn at UB; Kevin Chiem and Luis Martinez-Sobrido at the Texas Biomedical Research Institute; Edurne Rujas at The Hospital for Sick Children Research Institute in Canada and University of the Basque Country in Spain; Dushyant Jahagirdar and Joaquin Ortega at McGill University; Meera ...
Vancouver, BC, Canada - November 30, 2021 - Aspect Biosystems, a biotechnology company pioneering the development of bioprinted cell therapies as medicines of the future, is pleased to announce a research agreement with the University Health Network (UHN). Through this collaboration, Aspect Biosystems will combine its bioprinting technology with UHN’s protocols for ...
“Maryland is home to a thriving medical industry providing invaluable support to hospitals, research facilities, and private practices. I am excited to once again lead a delegation of outstanding companies as they pursue opportunities in the global marketplace and contribute to economic health and innovation in ...
-SITC 2021, re-hosted face to face meeting for the first time in 2 years due to COVID-19…topic for overcoming tolerance of Immuno-oncology -International researchers pay attention to immuno-oncology GI-101’s material excellence that had the mechanism of overcoming tolerance GI Innovation revealed KEYNOTE-B59’s clinical research process of ...
Of Cypriot descent, Dr Christofides started his career in 1973 at Hammersmith Hospital, London, as a research assistant where he developed immunoassay for Oestriol and provided routine biochemistry services to the Obstetrics and Gynaecology department. This was quickly followed by a move to Endocrinology for 9 years as a senior research officer ...
ABK Biomedical, Inc., an innovative, clinical stage medical device company dedicated to the research, development and commercialization of advanced embolic therapies, announced the approval and initiation of a First-in-Human study with Eye90 microspheres™, a Y90 radioembolization device, in collaboration with Auckland Hospital Research ...
In the last couple of years, the corona virus has caused a huge impact all across Europe. UVD Robots and Blue Ocean Robotics - the manufacturer of the autonomous disinfecting robot equipped with UV-C light - was selected by the European Commission, as a supplier for its autonomous disinfection robots to European Union hospitals in the fight against SARS-CoV-2 known as Coronavirus. Each year ...
Gamidor provides systems, reagents and services to clinical laboratories, hospitals and academic research institutions in Israel, and represents world-leading diagnostics companies, including Roche Diagnostics. ...